| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 157,408 shares worth roughly $644K on balance. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. RXRX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $29.56M | -50,000 | |
| CEO | 2.07M | $7.29M | - | |
| Dir | 1.48M | - | - | |
| CFO | 1.07M | $3.65M | - | |
| Other | 1.04M | $3.30M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2024 | Borgeson Blake69 | Director | Sell10b5-1 | 11,447 | $6.72 | $76,926.13 | -0.2% | +4.3% | -12.9% | |
| Oct 24, 2024 | Marriott Tina73 | President and COO | Sale+OE10b5-1 | 6,000 | $6.31 | $37,854.60 | -1.1% | +17.8% | -5.0% | |
| Oct 15, 2024 | Borgeson Blake69 | Director | Sell10b5-1 | 11,447 | $6.67 | $76,326.31 | -0.2% | +1.0% | +1.8% | |
| Oct 9, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE10b5-1 | 30,000 | $6.34 | $190,131.00 | -2.0% | +21.8% | -3.9% | |
| Oct 3, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell10b5-1 | 40,000 | $6.12 | $244,800.00 | -5.0% | +19.0% | -9.4% | |
| Oct 1, 2024 | Borgeson Blake69 | Director | Sell10b5-1 | 11,447 | $6.22 | $71,149.97 | -0.2% | +9.7% | -17.3% | |
| Sep 26, 2024 | Marriott Tina73 | President and COO | Sale+OE10b5-1 | 6,000 | $7.00 | $42,004.80 | -1.1% | +6.8% | -34.2% | |
| Sep 17, 2024 | Borgeson Blake69 | Director | Sell10b5-1 | 11,447 | $6.84 | $78,332.97 | -0.2% | +10.1% | -30.3% | |
| Sep 11, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE10b5-1 | 30,000 | $6.24 | $187,228.50 | -2.1% | +15.7% | -24.8% | |
| Sep 5, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell10b5-1 | 40,000 | $6.09 | $243,600.00 | -5.0% | +15.6% | -25.3% |